Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Due to increased demand, price hikes and long-term shortages, obtaining prescriptions for weight loss drugs such as ...

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...

Research has shown there are plenty of perks of using a medication like Ozempic for weight loss. But, given that this is a ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions.

Three doctors have expressed concerns to Newsweek about weight loss drugs for children, with research suggesting an initial reluctance to prescribe them.

IntraCare, a prominent Texas-based MSO, has partnered with the AI-powered intermittent fasting app MogulBody with a view to giving people better options for weight management.